Autophagy is orchestrated by the Atg1-Atg13 complex in budding yeast. Under nutrient-rich conditions, Atg13 is maintained in a hyperphosphorylated state by TORC1 kinase. After nutrient starvation, Atg13 is dephosphorylated, triggering Atg1 kinase activity and autophagy induction.
INTRODUCTION
Macroautophagy is a catabolic recycling pathway that is responsible of degradation of cytoplasmic components by targeting them to the vacuole under nutrient-depleted conditions (Nakatogawa et al. 2009, Wen and Klionsky 2016) . During the early steps of macroautophagy, phagophores are formed around cytoplasmic components (Suzuki et al. 2001 ) and nucleated around a phagophore assembly site (PAS) adjacent to vacuoles. Then, phagophores expand to form mature autophagosomes, which eventually fuse with the vacuole (Abeliovich et al. 2000) , wherein the contents engulfed within the autophagosomes are degraded (Epple et al. 2001 ). In addition to the degradation of random portions of the cytoplasm for recycling purposes under nutrient-depleted conditions, specific organelles or molecules can be targeted for degradation or processing under nutrient-repleted conditions (Farre and Subramani 2016) via selective autophagy. Selective autophagy pathways rely on the recognition of cargo via specific receptor proteins and the scaffold protein, Atg11 in yeast (Kamber et al. 2015 . One of the best-studied selective autophagy pathways is cytoplasm-to-vacuole (Cvt) pathway, which targets binding to Atg13 (Kijanska et al. 2010 . Conversely, the phosphorylation of Atg1-S34 is inhibitory for its kinase activity and also for autophagy (Yeh et al. 2011a) . Moreover, PKAdependent phosphorylation of Atg1 on two serine residues inhibit its localization to the PAS (Budovskaya et al. 2005) . As mentioned above, Atg13 is inhibited by TORC1-dependent phosphorylations on at least 8 serine residues (Kamada et al. 2010) . Overexpression of ATG13-8SA, in which 8 serines were mutated to alanines, results in autophagy induction that is uncoupled from TORC1 activity even when there is a genomic WT copy of ATG13 present. A recent study showed that the alanine substitution of 5 serine residues located in the MIM domain of Atg13 reduced Atg1-Atg13 binding and also impaired autophagy, suggesting that additional sites on Atg13 play a role in its regulation (Fujioka et al. 2014) .
Although the post-translational regulation of the Atg1 kinase complex has been well-studied, the phosphatases that are responsible of the reversal of these phosphorylations remain uncharacterized. Previous work showed that PP2A-type phosphatases might be involved in Atg13 dephosphorylation in mammals (Wong et al. 2015) . Furthermore, PP2A-type phosphatases are characterized as positive regulators of autophagy in mammals (Fujiwara et al. 2016 ) and in Drosophila (Banreti et al. 2012) . In budding yeast, PP2A-type phosphatases have also been implicated in the dephosphorylation of Atg13 (Yeasmin et al. 2016) ; however, the role of PP2Atype phosphatases on autophagy still remains under debate, as they were reported to be negative regulators of autophagy by another group (Yorimitsu et al. 2009 ).
Previous work from our lab has shown that DNA damage induces a targeted, Atg11-dependent selective autophagy pathway, which we coined genotoxin-induced targeted autophagy (GTA) (Dotiwala et al. 2013 , Eapen et al. 2017 . GTA requires the core autophagy machinery, Atg1, Atg13, Atg14, Atg16 and Atg18 as well as the scaffold Atg11, in addition to the kinases that are required for the maintenance of DNA damage checkpoint, Mec1/ATR and Rad53/CHK2. A genome-wide screen to find modulators of GTA yielded Pph3, a PP4-type phosphatase as a negative regulator specifically of GTA but not of rapamycin-induced autophagy (Eapen et al. 2017 ). Pph3 has been demonstrated to dephosphorylate and inactivate the targets of checkpoint kinases, including the DNA damage-specific phosphorylated histone subunit, g-H2AX and DNA damage checkpoint effector kinase Rad53 (Keogh et al. 2006 , Kim et al. 2011 , O'Neill et al. 2007 , Sun et al. 2011 . Consequently, deletion of PPH3 causes the cells to maintain a hyperactive DNA damage checkpoint.
Budding yeast's PP2C-type phosphatases, Ptc2 and Ptc3, are serine/threonine-phosphatase paralogs that arose from whole genome duplication and are largely redundant (Maeda et al. 1993 ). They dephosphorylate a variety of targets including those involved in the high-osmolarity glycerol pathway (Warmka et al. 2001 , Young et al. 2002 , the unfolded protein response (Welihinda et al. 1998) , the MAP-kinase pathway (Maeda et al. 1994 ) and the general stress response (Sharmin et al. 2014 ). In addition, these phosphatases counteract DNA damage checkpoint (DDC) signaling by directly dephosphorylating the central checkpoint kinase, Rad53 (Leroy et al. 2003) . As a result, similar to the deletion of PPH3, deletion of PTC2 and PTC3 causes the hyperactivation of DDC in response to DNA damage (Kim et al. 2011 , Leroy et al. 2003 .
Since Ptc2 and Ptc3 play a comparable role as Pph3 for DNA damage checkpoint inactivation (Kim et al. 2011) , we asked if Ptc2 and Ptc3 phosphatases have similar functions with Pph3 for GTA.
Contrary to the suppression of GTA by Pph3, we find that Ptc2 and Ptc3 are positive regulators not only of GTA, but also of rapamycin-induced macroautophagy and Cvt. Deletion of PTC2 and PTC3 causes the accumulation of hyperphosphorylated Atg1 even in nutrient-replete conditions. Atg1 hyperphosphorylation is dependent on the kinase activity of Atg1, and on Atg13 and Atg11.
In addition to Atg1, Atg13 is also maintained in a hyperphosphorylated state in the absence of PTC2 and PTC3. The autophagy defect in the ptc2D ptc3D strain is suppressed by the constitutively active ATG13-8SA allele. Based on these results, we propose that the phosphatases Ptc2 and Ptc3 promote autophagy by dephosphorylating and stimulating Atg1 kinase complex.
RESULTS

PP2C-type phosphatases Ptc2 and Ptc3 promote DNA-damaged induced and rapamycininduced autophagy
We used the GFP-Atg8 processing assay to monitor the autophagy induction in the phosphatase mutants . Upon autophagy induction, phosphatidylethanolamineconjugated Atg8 localizes to the PAS. While the PAS is expanding, Atg8 is localized to the inner autophagosome membranes. Once the autophagosome maturation is complete, Atg8 is delivered to the vacuole along with the autophagosomes and recycled. While Atg8 is degraded, the GFP moiety is resistant to vacuolar proteases. Hence, the ratio of free GFP to GFP-Atg8 on a Western blot serves as a reporter of autophagy activity [ Figure 1A ]. To investigate whether autophagy induction is altered in the phosphatase mutants, we transformed WT, ptc2D, ptc3D
and ptc2D ptc3D strains with a plasmid carrying GFP-Atg8 and induced autophagy by treating the cells with rapamycin to induce macroautophagy or with methyl methanesulfonate (MMS) to induce DNA damage and GTA (Eapen et al. 2017) . We collected samples 4h after treatment, extracted proteins and immunoblotted them for GFP. The single mutants ptc2D and ptc3D showed WT levels of autophagy induction in response to either rapamycin or MMS, except for a small but statistically significant defect in ptc3D for GTA [ Figure 1A ]. In contrast, the ptc2D ptc3D double mutant was significantly defective for both rapamycin-induced autophagy and GTA [ Figure 1B ].
We confirmed these results by live cell fluorescent imaging of GFP-Atg8. In WT cells, after rapamycin treatment, GFP-Atg8 localized to the PAS and to the vacuole as previously shown (Kirisako et al. 1999) . However, in the ptc2D ptc3D double mutant, the delivery of GFP-Atg8 to the vacuole was blocked significantly, and the vacuolar GFP signal in the double phosphatase mutant was significantly reduced compared to WT cells [ Figure 1C ]. We observed the same block after MMS treatment [ Supplementary Figure 1 ]. GFP-Atg8 localization at the PAS after autophagy induction was more pronounced in the ptc2D ptc3D double mutant compared to WT. Moreover, in some cells, instead of one prominent GFP-Atg8 focus, there are multiple, less intense foci, that colocalize with mCherry-Ape1 foci 1h after rapamycin treatment [ Figure 1C ]. Taken together, these results suggest that Ptc2 and Ptc3 act redundantly to promote DNA damage-induced autophagy, as well as macroautophagy.
PP2C-type phosphatases Ptc2 and Ptc3 promote cytoplasm-to-vacuole targeting pathway
After establishing that Ptc2 and Ptc3 promote macroautophagy, we asked if they are also involved in selective autophagy. The prototypic selective autophagy pathway in yeast is the cytoplasm-to-vacuole (Cvt) pathway (Lynch-Day and Klionsky 2010). To assay Cvt activity quantitatively, we used the Ape1 maturation assay (Torggler et al. 2017) . Ape1 is synthesized in the cytoplasm as a precursor peptide (prApe1), and then delivered to the vacuole through the Cvt pathway for its maturation (mApe1) by the removal of its propeptide (Lynch-Day and Klionsky 2010). Maturation of Ape1 can be detected on a Western blot with an Ape1-specific antibody that recognizes both forms of the protein (Klionsky et al. 1992) . We collected samples from WT and phosphatase null cultures after rapamycin and MMS treatment, as indicated before, and blotted them with anti-Ape1 antibody to assay Cvt activity. We found that deletion of PTC2 and PTC3 impaired Ape1 maturation under basal conditions, as well as after rapamycin or MMS treatments [ Figure 2A ]. We confirmed the inhibition of Ape1 delivery to the vacuole in the absence of Ptc2 and Ptc3 phosphatases by live cell microscopy, by using an N-terminus mCherrytagged Ape1. We observed the accumulation of abnormally large mCherry-Ape1 foci at the PAS in the ptc2D ptc3D cells 4h after rapamycin treatment [ Figure 2B ]. Taken together, these results suggest that the delivery of Cvt vesicles in the absence of Ptc2 and Ptc3 is significantly impaired.
The delivery of prApe1 to the vacuole is dependent on Atg1 and Atg13 (Kamada et al. 2000) and the adapter protein Atg11 (Yorimitsu and Klionsky 2005) . To see if the Cvt defect of the ptc2D ptc3D cells is due to the mislocalization of these essential Cvt machinery, we assayed the localization of Atg1, Atg11 and Atg13 under nutrient replete conditions in WT and ptc2D ptc3D cells by using fluorescent live cell imaging. We observed weak Atg1 puncta in the absence of Ptc2 and Ptc3 phosphatases compared to WT. Moreover, in the absence of Ptc2 and Ptc3, Atg11 and Atg13 did not form visible puncta [ Figure 2C ], suggesting that phosphatase null cells are defective in recruitment of the ATG machinery required for proper Cvt function.
We also observed that the ptc2D ptc3D mutants have abnormal vacuoles by FM4-64M staining [ Supplementary Figure 2 ], reminiscent of class-B vps mutants in their alveolar appearance (Vida and Emr 1995) . Taken together, these data indicate that Ptc2 and Ptc3 are required for proper localization of autophagy proteins and the delivery of the Cvt vesicles to the vacuoles.
Ptc2 and Ptc3 phosphatases regulate the localization of Atg proteins to the PAS
Atg1, Atg13 and Atg17 are the part of the core autophagy pathway; and are required for proper autophagy function (Kabeya et al. 2005 , Kamada et al. 2000 . Therefore, we asked if this core autophagy machinery is recruited to PAS properly in the absence of Ptc2 and Ptc3 phosphatases after autophagy induction. We used fluorescently-tagged Atg1, Atg11, Atg13 and Atg17 and assayed their localization with live cell fluorescent imaging 4h after rapamycin treatment. Similar to what we observed under nutrient-replete conditions, Atg1 was able to form weak puncta in the absence of Ptc2 and Ptc3 phosphatases [ Figure 3A ]. However, the number of cells that had Atg11, Atg13 and Atg17 foci were significantly reduced in the ptc2D ptc3D cells [ Figure 3B , Supplementary Figure 3 ]. These results suggest that Ptc2 and Ptc3 are required for the proper recruitment of autophagy proteins to the PAS under nutrient starvation conditions.
Atg1 is maintained in a hyperphosphorylated state in the absence of Ptc2 and Ptc3
Next, we investigated whether Ptc2 and Ptc3 act directly on TORC1 to regulate autophagy, since TORC1 signaling is inhibitory to macroautophagy. As a read-out of TORC1 activity, we assayed the phosphorylation levels of the AGC kinase Sch9, a direct target of TORC1 (Urban et al. 2007) . We observe that both in WT and ptc2D ptc3D double mutant cells, Sch9 was phosphorylated under nutrient-replete conditions and was dephosphorylated upon rapamycin treatment [ Supplementary Figure 4 ], indicating that the Ptc2 and Ptc3 phosphatases are likely to exert their effects on autophagy by acting on downstream targets of TORC1 rather than on TORC1 itself. Atg1 is regulated extensively by phosphorylations, some of which have been shown to be inhibitory for autophagic activity. Ptc2 and Ptc3 could promote autophagy by relieving these inhibitory phosphorylations. To monitor the phosphorylation of Atg1 in ptc2D ptc3D double mutant, we used a strain which carries an N-terminus 2XFLAG-tagged Atg1 allele (Kamber et al. 2015) . Starvation-induced inhibition of TORC1 and PKA causes the activation of Atg1 through autophosphorylation (Kamada et al. 2000 , Stephan et al. 2009 ). Atg1 autophosphorylation requires the presence of Atg13, as binding to dephosphorylated Atg13 stimulates Atg1's kinase activity after autophagy induction . We confirmed that Atg1 is phosphorylated 4h after rapamycin or MMS treatment, in an Atg13-dependent manner. In ptc2D and ptc3D single mutants, Atg1 was phosphorylated upon MMS or rapamycin treatment similar to WT [Supplementary Figure 5 ]. However, in the ptc2D ptc3D double mutant, we detected an accumulation of high molecular weight Atg1 bands in nutrient-replete conditions, as well as after the induction of autophagy. The appearance of these Atg1 bands in the double phosphatase mutant was Atg13-dependent, as the mobility of Atg1 in atg13D ptc2D ptc3D triple mutant was comparable to the atg13D single mutant [ Figure 4A ].
Recent work from Denic lab showed that Atg1's kinase activity under nutrient replete conditions is stimulated by binding to Atg19-prApe1 Cvt cargo complex, as well as the adapter protein Atg11 (Kamber et al. 2015) . We asked if the hyperphosphorylated Atg1 species we observe in the absence of Ptc2 and Ptc3 phosphatases under nutrient replete conditions could be due to the overstimulation of Atg1 by Cvt cargo binding. To test this, we measured the phosphorylation levels of Atg1 in the ptc2D ptc3D cells lacking Atg11, Atg19 or Atg1 before or after rapamycin treatment. Interestingly, the appearance of hyperphosphorylated Atg1 species was dependent on Atg11 [ Figure 4B ], but not on Atg19 or Ape1 [Supplementary Figure 6 ]. Although in the ptc2D ptc3D atg11D triple mutant, Atg1 hyperphosphorylation was reduced, this was not enough to rescue the macroautophagy defect of the ptc2D ptc3D as judged by the GFP-Atg8 processing [ Figure 4B ]. We conclude that Atg1 phosphorylation is counteracted by Ptc2 and Ptc3 phosphatases under nutrient-replete and starvation conditions.
Previous reports indicate that Atg1 autophosphorylation of residue T226 in the activation loop domain is required for Atg1's kinase activity and proper autophagy induction (Kijanska et al. 2010 ). An atg1-T226A point mutation blocks autophagy activity as well as the Atg1's kinase activity . We asked if the high mobility of Atg1 bands seen in ptc2D ptc3D double mutant were dependent on Atg1's kinase activity. We created an atg1-T226A mutant at the endogenous locus by using CRISPR/Cas9 (see Methods) in WT and ptc2D ptc3D backgrounds that carry an epitope-tagged Atg1. As expected, the atg1-T226A point mutant abolished the autophagy-dependent autophosphorylation of Atg1 in WT. Additionally, the atg1-T226A substitution blocked the appearance of slower-migrating Atg1 bands in the ptc2D ptc3D double mutant [ Figure 5A ]. Autophagy was completely blocked in the strains carrying the atg1-T226A allele, in agreement with the previously shown role of this site in Atg1's kinase activity ). These data demonstrate that Atg1 is extensively autophosphorylated in the absence of PP2C type phosphatases Ptc2 and Ptc3 irrespective of autophagy induction, and PP2C-type phosphatases counteract these phosphorylations.
In addition to T226, Atg1 is regulated by phosphorylation of serine 34; however, the phosphorylation of Atg1-S34 is inhibitory for autophagy as well as for Atg1's kinase activity (Yeh et al. 2011a) . To see if Ptc2 and Ptc3 exert their effect on Atg1 by reversing Atg1-S34 phosphorylation, we created endogenous atg1-S34A and atg1-S34D point mutants by using CRISPR/Cas9 in WT and phosphatase null backgrounds. We induced autophagy by the addition of rapamycin for 4h and measured the GFP-Atg8 processing together with Atg1 mobility shift.
Our data show that autophagy is impaired in atg1-S34D point mutant as previously shown (Abeliovich et al. 2000) , but this substitution is not sufficient to fully eliminate the autophosphorylation of Atg1 after autophagy induction [ Figure 5B ]. The atg1-S34D substitution reduced the levels of hyperphosphorylated Atg1 detected in ptc2D ptc3D, which could be due to the decreased level of Atg1 kinase activity observed in the S34D mutant (Yeh et al. 2011a) , and hence, the defects in Atg1 autophosphorylation observed in ptc2D ptc3D double mutants. In contrast, the autophagy-proficient atg1-S34A point mutant failed to rescue the autophagy defect in the double phosphatase mutants, suggesting that additional Atg1 phosphorylation sites are involved in this regulation or that S34 specifically is not regulated by PP2C phosphatases.
Prior research suggested that the more slowly-migrating Atg1 species observed post-autophagy induction is due to the phosphorylation of site S390 and that the Atg1 phospho-shift detected upon autophagy induction is lost in an atg1-S390A point mutant (Yeh et al. 2011a) . We asked if the phosphorylation of S390 contributed to the higher migrating Atg1 bands in the ptc2D ptc3D double mutant. We created atg1-S390A and atg1-S34A single and double mutants with CRISPR/Cas9 in WT and ptc2D ptc3D strains and assayed the phosphorylation status of Atg1 before or after the induction of autophagy by rapamycin treatment. We observed a more prominent rapidly-migrating band in the atg1-S34A,S390A ptc2D ptc3D quadruple mutant; however, neither the atg1-S34A and atg1-S390A single mutants, nor the atg1-S34A,S390A double mutant was able to rescue the autophagy defect of ptc2D ptc3D [Supplementary Figure   7 ]. Collectively, these results suggest that Ptc2 and Ptc3 are required for Atg1 dephosphorylation; however, the S34 and S390 sites that were previously implicated in Atg1 regulation are either not directly targeted by Ptc2 and Ptc3, or there are additional sites, yet to be identified, which play a role in Atg1 regulation.
Atg13 is hyperphosphorylated in ptc2D ptc3D double mutant
As mentioned previously, Atg13 is hyperphosphorylated prior to autophagy induction by the action of TORC1 and PKA kinases. Upon nutrient starvation or rapamycin treatment, TORC1 activity is downregulated and Atg13 is rapidly dephosphorylated. This step is required for proper autophagy induction, since overexpression of a constitutively active ATG13-8SA allele is sufficient to induce autophagy in cells carrying a wild-type ATG13 gene (Kamada et al. 2010) . We hypothesized that one way by which Ptc2 and Ptc3 could promote autophagy is by mediating the dephosphorylation of Atg13 during initiation of autophagy. If that were the case, we would expect to detect constitutively phosphorylated Atg13 in ptc2D ptc3D mutants, regardless of the status of TORC1. To test this hypothesis, we aimed to detect the Atg13 phosphorylation in the phosphatase mutants. To be able to detect the endogenous Atg13, we created a strain that bears a genomic 10XMYC-Atg13. We assayed the phosphorylation of Atg13 in ptc2D ptc3D double mutant cells prior to autophagy induction and after 4h rapamycin treatment by immunoblotting.
We detected an accumulation of apparently more hyperphosphorylated Atg13 prior to autophagy induction in the ptc2D ptc3D double mutant compared to WT [ Figure 6A ]. After autophagy induction, Atg13 was only partially dephosphorylated in ptc2D ptc3D cells, whereas in WT cells Atg13 was fully dephosphorylated upon autophagy induction as expected. Autophagy induction in the ptc2D ptc3D double mutant cells that contain an epitope-tagged Atg13 allele was blocked as expected [ Figure 1A , Figure 6A ]. These results suggest that the phosphatases Ptc2 and Ptc3 are involved in dephosphorylation of Atg13. We also observed that Atg13 was dephosphorylated in the atg1-T226A strain just like WT, suggesting that the dephosphorylation of Atg13 is independent of autophagy flux and Atg1's kinase activity [ Supplementary Figure 8 ].
Atg1 and Atg13 interact prior to autophagy induction (Kraft et al. 2012) ; however, hyperphosphorylated Atg13 has been shown to have weaker affinity for Atg1 (Kabeya et al. 2005 , Kamada et al. 2000 . Moreover, the binding of Atg13 stimulates Atg1's kinase activity. One explanation for the autophagy defect of the ptc2D ptc3D cells is the inability to form a functional Atg1 complex due to the accumulation of hyperphosphorylated Atg1 and Atg13 species. To test this, we co-immunoprecipitated Atg13-13XMYC together with 2XFLAG-Atg1 [ Figure 6B ]. We found comparable levels of association of Atg1 with Atg13 in WT and phosphatase null strains as well as in a strain that carries the kinase defective atg1-T226A prior to autophagy induction [ Figure 6C ]. These results demonstrate that the hyperphosphorylated Atg1 and Atg13 species observed in the phosphatase null strain still can form a complex when TORC1 is active, and that the autophagy defect seen in the ptc2D ptc3D null strain is not due to a defect in Atg1-Atg13 complex formation.
The autophagy defect of the ptc2D ptc3D null cells is rescued by expression of constitutively active Atg13
As mentioned previously, the overexpression of the constitutively active ATG13-8SA is sufficient to induce autophagy that is uncoupled from TORC1 activity (Kamada et al. 2010) . We asked if this would also be sufficient to bypass the autophagy defect of ptc2D ptc3D double mutant. Our data show that the overexpression of the constitutively active ATG13-8SA allele in a PP2C phosphatase null strain promoted autophagy to near-WT levels [ Figure 7A ]. Based on these data, we argue that the defect seen in the phosphatase null strain is directly due to a failure to dephosphorylate Atg13.
Overexpression of the constitutively active ATG13-8SA failed to reduce the hyperphosphorylation of Atg1 in ptc2D ptc3D [ Figure 7B ]. Moreover, the overexpression of constitutively active ATG13-8SA allele in the atg1-T226A background did not restore the autophagy defect of atg1-T226A, as opposed to the rescue observed in the ptc2D ptc3D strain, as we and others have previously shown (Kamada et al. 2010) . Taken together, these results suggest that despite the extensive autophosphorylation, the kinase activity and Atg13 binding affinity of Atg1 are not impaired in the absence of Ptc2 and Ptc3. These data demonstrate that the impaired autophagy activity in the ptc2D ptc3D mutant strain is due to a defect in the dephosphorylation of Atg13 and not due to an inherent defect in Atg1's kinase activity.
We noticed that overexpression of WT ATG13 or presence of ATG13-8SA without the overexpression resulted in an increase in autophagy induction [ Figure 7A and B]. The overexpression of ATG13 has been shown to exacerbate the activating autophosphorylation of Atg1 at site T226A ), suggesting that Atg13 abundance can also regulate autophagy. To distinguish between these possibilities, we integrated the atg13-8SA allele into the genome, under the control of Atg13's endogenous promoter in WT and ptc2D ptc3D backgrounds. As expected, the atg13-8SA strain showed increased levels of GFP-Atg8 cleavage even prior to rapamycin treatment [ Figure 8A ]. The levels of autophagy flux increased only modestly upon rapamycin treatment in this strain, once again reinforcing the idea that the phosphorylation of Atg13 at these 8 sites by the action of TORC1 kinase is the main inhibitory control over autophagy induction. The GFP-Atg8 cleavage observed in the ptc2D ptc3D atg13-8SA mutant was significantly higher compared to ptc2D ptc3D; however, introducing the atg13-8SA mutations did not restore WT levels of autophagy to the phosphatase null strain [ Figure 8B ].
Moreover, we observed an intermediate level of GFP localization to the vacuole in the ptc2D
ptc3D atg13-8SA triple mutant, agreeing with the GFP-Atg8 cleavage assay results [ Figure 8C ].
These data suggest that Ptc2 and Ptc3 are involved in the regulation of other proteins in the autophagy pathway in addition to Atg13.
DISCUSSION
We have previously shown that DNA damage induces a targeted autophagy pathway, termed GTA. This pathway is selective, and requires all the core ATG machinery, in addition to the scaffold protein Atg11 (Eapen et al. 2017) . Moreover, the magnitude of GTA is positively correlated with the magnitude of DNA damage. The PP2C phosphatases Ptc2 and Ptc3 were previously shown to be negative regulators of DNA damage checkpoint response, specifically in regulating the autophosphorylation of Rad53/CHK2 (Guillemain et al. 2007 , Leroy et al. 2003 . Thus, in the absence of Ptc2 and Ptc3, even after cells have repaired DNA damage, they fail to exit from the checkpoint arrest and deactivate Rad53. Rad53 activation has also been shown to be critical for the induction of GTA (Eapen et al. 2017) . For this reason, we expected to observe an increase in the GTA response in the absence of these phosphatases. However, we found a significant decrease in rapamycin-induced macroautophagy, as well as in GTA suggesting that Ptc2 and Ptc3 redundantly promote autophagy. In addition to the macroautophagy defect, ptc2D ptc3D mutants exhibit a strong Cvt defect. Ape1 maturation observed under nutrient-replete conditions is almost fully blocked in the absence of Ptc2 and Ptc3. We also observe very large Ape1 complexes after rapamycin treatment, and a defect in the recruitment of proteins that are essential to Cvt function ptc2D ptc3D mutant strain. Given that Ptc2 and Ptc3 do not act directly on TORC1, based on our data, we conclude that Ptc2 and Ptc3 modulate the core autophagy machinery downstream of TORC1.
To identify the targets of Ptc2 and Ptc3 among the core ATG machinery, we turned our attention to the Atg1 kinase complex. We observe that Atg1 is maintained in an hyperphosphorylated state in the ptc2D ptc3D double mutant. The appearance of the hyperphosphorylated Atg1 species is Atg13 and Atg11-dependent. Moreover, reducing the kinase activity of Atg1 by introducing a T226A substitution blocked the appearance of these bands. Based on these results, we suggest that the basal level binding between the Atg1, Atg13 and Atg11 under nutrient-replete conditions stimulates the kinase activity of Atg1 as previously observed (Kamber et al. 2015) , and this results in extensive autophosphorylation of Atg1. Under normal circumstances, these phosphorylations are counteracted by Ptc2 and Ptc3, but in the absence of these phosphatases, Atg1 is maintained in a hyperphosphorylated state. Interestingly, the aberrant hyperphosphorylated Atg1 species in ptc2D ptc3D mutants are not dependent on Atg19-prApe1 cargo complex. We do not rule out that under normal conditions, Atg1's kinase activity is stimulated by these proteins; although, we also observed that in the absence of Ptc2 and Ptc3, Atg11 is not recruited to the PAS. This implies that in the absence of Ptc2 and Ptc3 phosphatases, Atg1-Atg19-prApe1 binding is impaired due to the failure to recruit Atg11. Previous research showed that in the absence of Atg11, Atg1 and Atg13 formed a complex without Atg19, supporting this hypothesis (Kamber et al. 2015) . Our data also imply that Atg1-Atg13 and Atg11 can interact without being localized to the PAS, since the localization of Atg13 and Atg11 is significantly impaired in the absence of Ptc2 and Ptc3 phosphatases.
PAS organization is a highly regulated process. Previous work demonstrated that the localization of the scaffold protein Atg17 to PAS is a prerequisite for Atg13 and Atg1 recruitment (Suzuki et al. 2007 ). In agreement, our data show that Atg1, Atg13 and Atg17 localization to PAS in the absence of Ptc2 and Ptc3 mutants is significantly impaired. This defect could be due to the regulation of Atg17 directly by Ptc2 and Ptc3 phosphatases, or a defect in Atg13-Atg17 binding.
Indeed, Atg13-Atg17 binding is improved upon autophagy induction and Atg13 dephosphorylation (Kabeya et al. 2005 ). Therefore, it is possible that Atg13-Atg17 binding is weaker in the absence of Ptc2 and Ptc3 phosphatases, due to the hyperphosphorylation of Atg13.
After establishing that Atg1 is extensively autophosphorylated in ptc2D ptc3D mutant strain, we focused on previously characterized Atg1 phosphorylation sites to identify the sites that are involved in the regulation of Atg1 by these phosphatases. The phosphorylation of site Atg1-S34 has previously been characterized as inhibitory to autophagy activity (Yeh et al. 2011a ). If the autophagy defect seen in the phosphatase null strain is due to the persistence of the inhibitory phosphorylation of Atg1 at site S34, introducing an alanine substitution should rescue this defect.
However, ptc2D ptc3D atg1-S34A triple mutant is as defective as the ptc2D ptc3D double mutant for GFP-Atg8 processing, suggesting that the autophagy defect seen in the phosphatase mutants is not only due to the inhibitory phosphorylation of S34; additional sites are involved in the regulation. The atg1-S34D substitution, as well as the atg1-S34A,S390A substitutions decreased the abundance of the higher molecular weight Atg1 bands detected in the phosphatase null strain. But this could be due to the decrease in Atg1's kinase activity in these mutants, hence, decreased levels of Atg1 autophosphorylation (Yeh et al. 2011a) . Alternatively, the effect of Ptc2 and Ptc3 on Atg1 could be indirect.
Atg13, an essential component of the core autophagy machinery, is kept in a hyperphosphorylated and inhibited state under nutrient-replete conditions by TORC1 and PKAdependent phosphorylations, and its dephosphorylation is critical for the autophagy induction.
The phosphatases that are responsible for regulating Atg13 remain unidentified. Our data show that, in the absence of PP2C phosphatases, Atg13 is hyperphosphorylated irrespective of the TORC1 status, indicating that Ptc2 and Ptc3 are involved in dephosphorylation of Atg13. Previous work showed that the overexpression of constitutively active ATG13-8SA in a cell carrying a chromosomal ATG13 allele can cause autophagy induction when TORC1 is active, in an Atg1dependent manner (Kamada et al. 2010) . The overexpression of this allele was also able to induce autophagy in the ptc2D ptc3D strain. Here we show the overexpression of ATG13-8SA is also able to sufficient to induce autophagy in the ptc2D ptc3D strain. Moreover, a single integrated atg13-8SA allele is able to partially rescue the autophagy defect of the phosphatase null strain. The atg13-8SA mutant induces autophagy under nutrient-replete conditions whereas the ptc2D ptc3D atg13-8SA strain does not. These results indicate that the autophagy defect observed in the absence of Ptc2 and Ptc3 is mainly due to a defect in the dephosphorylation of Atg13, but Atg13 is not the sole target of these phosphatases. A mass spectrometry study by Fujioka et al. suggested that there are 51 phospho-sites on Atg13 whose phosphorylation levels decrease after rapamycin treatment (Fujioka et al. 2014 , Kamada et al. 2010 . It is also possible that Ptc2 and Ptc3 regulate additional sites on Atg13 in addition to the sites that are targeted by TORC1.
Atg13 and the kinase activity of Atg1 are essential for Cvt function; however, Cvt can occur under nutrient rich conditions without TORC1 inhibition or without Atg13 dephosphorylation (Kamada et al. 2000 . Therefore, the Cvt defect of the ptc2D ptc3D double mutant is unlikely to be dependent on the accumulation of hyperphosphorylated Atg13. We show that in the absence of Ptc2 and Ptc3 phosphatases, the localization of Atg1, Atg11 and Atg13 are impaired, all of which are required for Cvt function, suggesting that there is a fundamental defect in PAS organization. It is possible that Ptc2 and Ptc3 modulate proteins that play an important role for selective autophagy but dispensable for the starvation-induced autophagy, such as Atg11 or Atg19 (S. V. Scott et al. 2001, Yorimitsu and Klionsky 2005) .
We conclude that the Ptc2 and Ptc3 phosphatases are positive regulators of autophagy. They are involved in the dephosphorylation of Atg13 to stimulate the kinase activity of the Atg1 kinase complex to allow proper autophagy induction. The autophagy defect of the phosphatase null strain can be rescued by the overexpression of constitutively active ATG13-8SA allele or expressing the atg13-8SA under its endogenous promoter. Moreover, according to our results, Atg1 is constitutively autophosphorylated under nutrient replete conditions. These phosphorylations are not inhibitory to its kinase activity and are counteracted by PP2C type phosphatases Ptc2 and Ptc3. The effect of these autophosphorylations on Atg1 regulation is still not known.
MATERIALS AND METHODS
Yeast media, strains and plasmids: Saccharomyces cerevisiae strains used in this study are derivatives of JKM179 or BY4741 ( Supplementary Table 3 ). Plasmids used in the study are listed in Supplementary Table 1 . Deletions of ORFs were created by using the one step PCR homology cassette amplification and transformed using high efficiency yeast transformation methods (Amberg et al. 2006 , Wach et al. 1994 . The primer sequences used for the deletions are available upon request. Atg1 point mutants were created by using CRISPR/Cas9 as previously explained (Anand et al. 2017) . The sequences of the single-stranded oligonucleotide DNA (ssODN) templates used to create CRISPR/Cas9-mediated point mutants are indicated in Supplementary Table 2 , the CRISPR/Cas9 plasmids are indicated in Supplementary Table 1 . 2XFLAG-Atg1 in the Atg13-13xMYC strain was created by targeting the N-terminus of Atg1 with CRISPR/Cas9 and using a PCR-amplified fragment as template. N-terminus mCherry-tagged Ape1 and N-terminus 10xMYC-tagged Atg13 were created by targeting the N-terminus of the ORFs with CRISPR/Cas9. The Atg13-13xMYC epitope-tagged strain was created by transforming cells with PCR-amplified cassettes that contain homology to Atg13 C-terminus (Longtine et al. 1998 ). The GFP-Atg8, GAL-ATG13, GAL-ATG13-8SA, mCherry-Ape1 and 2GFP plasmids were a gift from Yoshiaki Kamada, National Institute of Basic Biology, Okazaki, Japan (Kamada et al. 2010) . The 2XFLAG-Atg1 VDY630 strain was a gift from Vladimir Denic, Harvard University, Cambridge, MA, USA (Kamber et al. 2015) . C-terminus 2XGFP tagging of the Atg1, Atg11, Atg13 and Atg17 was performed as previously described (Li et al. 2015) . Yeast strains were grown in YEPD (1% yeast extract, 2% peptone, 2% dextrose) for normal growth conditions. GFP-Atg8 processing assay: Cells were grown in YEPD overnight, washed into YEP-lactate (YEP containing 3% lactic acid) and inoculated into YEP-lac so that they reach exponential phase. For galactose induction experiments, cells were treated with a final concentration of 2% galactose.
We used MMS at a final concentration of 0.04% to induce GTA, or rapamycin at a final concentration of 200ng/ml to induce macroautophagy.
Sample collection and Western blotting:
Cells were harvested from 50 ml of the early exponential phase culture (1-10 x 10 6 cells/ml) by centrifugation. Cell pellets were washed in 1 ml of 20% TCA and quick-frozen on dry ice. TCA protein extraction was carried out as previously described (Eapen et al. 2017) . For pulldown experiments, approximately 500 µg of cell pellet was harvested and washed with ice cold 1 ml 50 mM Tris, 5 mM EDTA solution. The samples were kept on dry ice. For protein extraction, cells were resuspended in lysis buffer (50 mM HEPES pH7.5, 150 mM NaCl, 2 mM EDTA, 0.5% IGEPAL), supplemented with protease inhibitors. Cell lysis was performed by vortexing with acid-washed glass beads. The crude extract was collected and cleared by centrifugation at maximum speed twice for 15 min at 4 0 C. An equal volume of the cleared lysate was mixed with Protein G-agarose beads (Roche) pre-incubated with anti-MYC antibodies. After the overnight incubation, the beads were washed twice with 1ml lysis buffer containing protease inhibitors, and the samples were eluted in 100 µl 6X Laemmli buffer containing 0.9% B-mercaptoethanol by boiling at 95 0 C for 5 min. Samples were run on 6% gels for the detection of hyperphosphorylated Atg1 and Atg13 species, 7% gels for Sch9 and Ape1 detection, and 10% gels for GFP-Atg8, Pgk1, and Atg13 overexpression assays. Blotting was performed by using anti-GFP antibody (AbCam ab-6556), anti-FLAG antibody (Millipore Sigma A2220), anti-Pgk1 antibody (AbCam ab113687), anti-MYC antibody (AbCam 9E10), anti-Atg13 antibody, anti-Ape1 antibody, and anti-Sch9 antibody. Anti-Atg13 and anti-Ape1 antibodies were a gift from Dr. Daniel Klionsky (Klionsky et al. 1992 , Miller-Fleming et al. 2014 . Anti-Sch9 antibody was a gift from Dr. Robbie Loewith (Urban et al. 2007 ). Membranes were developed by using Amersham ECL Prime Western Blotting Detection Reagent and visualized by BioRad Gel Doc XR+ gel documentation system. ImageLab software from BioRad was used to crop and quantify the immunoblots.
Fluorescent microscopy: Cells were grown in YEP-lactate overnight and treated with MMS and rapamycin as described previously (Eapen et al. 2017) . Strains that contain mCherry-Atg8 plasmids were grown in leucine drop-out media with 2% dextrose. Cells were harvested by centrifugation at 3000 rpm for 1 min and then washed into synthetic complete media prior to imaging. The images were taken with Nikon Eclipse E600 microscope and processed with Fiji software. FM4-64 dye (Invitrogen) stock solution was prepared and used as previously described (Vida and Emr 1995) . Cells containing Atg11, Atg13 and Atg17 foci were counted manually. For each condition, more than 150 cells were quantified. Atg13-GFP and Atg17-GFP localization in ptc2Δ ptc3Δ and WT cells 4h after rapamycin treatment.
Percentage of cells with visible Atg13 or Atg17 foci were quantified and plotted. For each condition, more than 150 cells were counted. Atg1-Atg13 binding in ptc2Δ ptc3Δ and atg1-T226A. FLAG-Atg1 was coimmunoprecipitated with Atg13-MYC in WT, ptc2Δ ptc3Δ and atg1-T226A and blotted for FLAG, to detect Atg1 and for MYC, to detect Atg13. C. Normalized Atg1-Atg13 binding was calculated as a ratio of FLAG-Atg1 band intensity to Atg13-MYC band intensity at 0h for WT, atg1-T226A and ptc2Δ ptc3Δ and then normalized to WT. FLAG-Atg1 strains carrying the WT ATG13 or ATG13-8SA galactose-inducible plasmids were grown and induced as explained previously. Samples were collected and blotted for Atg13, FLAG (for Atg1 detection) and for GFP. Figure 8 . A. GFP-Atg8 processing in strains that carry atg13-8SA at endogenous locus after 4h rapamycin treatment. Samples were collected and blotted as described in Figure 1 . B.
Quantification of GFP-Atg8 processing in WT, ptc2Δ ptc3Δ, atg13-8SA and ptc2Δ ptc3Δ atg13-8SA strains. GFP-Atg8 processing in these strains were calculated from 3 independent experiments, averaged and plotted. Error bars represent standard error. P = 0.04. C. GFP-Atg8 localization in WT, ptc2Δ ptc3Δ, atg13-8SA and ptc2Δ ptc3Δ atg13-8SA strains 4h after rapamycin treatment. Samples were collected and analyzed by blotting. Figure 6 . Atg1 hyperphosphorylation in WT, ape1Δ, atg19 Δ, ptc2Δ ptc3Δ, ape1Δ ptc2Δ ptc3Δ and atg19Δ ptc2Δ ptc3Δ mutant strains. Cells were treated with rapamycin as previously explained and blotted for FLAG, Pgk1 and GFP. Figure 7 . Atg1 hyperphosphorylation in WT, atg1-S34A, atg1-S390A, atg1-S34AS390A, ptc2Δ ptc3Δ atg1-S34A, ptc2Δ ptc3Δ atg1-S390A and ptc2Δ ptc3Δ atg1-S34AS390A mutant strains 4h after rapamycin treatment. Samples were blotted for Pgk1 as loading control and GFP to measure percent GFP cleavage. Figure 8 . Atg13 and Atg1 hyperphosphorylation in WT, ptc2Δ ptc3Δ and atg1-T226A mutant strains 4h after rapamycin treatment. Samples were also blotted for Pgk1 for loading control and GFP to measure percent GFP-Atg8 cleavage. 
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